Hypofraction Adjuvant Radiation
Showing 1 - 25 of >10,000
Resectable Head and Neck Squamous Cell Carcinoma Trial in Milwaukee (42 Gy Radiation Therapy, 39 Gy Radiation Therapy, 32.5 Gy
Suspended
- Resectable Head and Neck Squamous Cell Carcinoma
- 42 Gy Radiation Therapy
- +2 more
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Jan 13, 2023
Chemotherapy and Tislelizumab With Split-course HFRT for Locally
Recruiting
- Rectal Cancer
- Radiation Oncology
- split-course HFRT
- +2 more
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Apr 26, 2022
Radiotherapy, Breast Cancer, Relaxation Trial in Munich (Respiratory training and relaxation techniques under adjuvant radiation
Recruiting
- Radiotherapy
- +3 more
- Respiratory training and relaxation techniques under adjuvant radiation therapy in DIBH in breast cancer
-
Munich, GermanyDepartment of Radiation Oncology, Technical University of Munich
Aug 1, 2023
Early-stage Breast Cancer Trial in Brno (APBI, WBI)
Completed
- Early-stage Breast Cancer
- APBI
- WBI
-
Brno, Czech Republic, CzechiaMasaryk Memorial Cancer Institute
Aug 17, 2023
Brain Metastases Trial (Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Stereotactic Radiation Therapy)
Not yet recruiting
- Brain Metastases
- Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)
- Stereotactic Radiation Therapy
- (no location specified)
Jun 2, 2023
Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)
Active, not recruiting
- Adenocarcinoma of the Prostate
- Androgen suppression plus radiation therapy
-
Montreal, Quebec, Canada
- +1 more
Jan 30, 2023
HER2-positive Breast Cancer Trial (Standard of Care Adjuvant Breast Radiation, Standard of Care HER2-targeted Therapy Without
Not yet recruiting
- HER2-positive Breast Cancer
- Standard of Care Adjuvant Breast Radiation
- Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
- (no location specified)
Jan 20, 2023
Soft Tissue Sarcoma Trial in France (Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior
Not yet recruiting
- Soft Tissue Sarcoma
- Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior to surgery.
- Patient will undergo surgery before receive the adjuvant hypofractionated radiation therapy (40 Gy in 15 fractions).
-
Bordeaux, France
- +10 more
Aug 28, 2023
Omitting Clinical Target Volume in Radical Treatment of
Not yet recruiting
- Immunotherapy
- +3 more
- IMRT+adjuvant immunotherapy
- (no location specified)
Jun 9, 2023
6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly
Withdrawn
- MGMT-Methylated Glioblastoma
- Delay of TMZ
- Standard of Care (SOC) Adjuvant TMZ (no intervention
- (no location specified)
Aug 5, 2022
Hepatocellular Carcinoma, Narrow Margin, Adjuvant Stereotactic Body Radiotherapy Trial in Hangzhou (stereotactic body radiation
Not yet recruiting
- Hepatocellular Carcinoma
- +3 more
- stereotactic body radiation therapy
- regular follow-up
-
Hangzhou, Zhejiang, Chinathe second affiliated hospital of Zhejiang University
Nov 3, 2022
3D Specimen Maps for RT Planning
Recruiting
- Head and Neck Cancer
- +2 more
-
Nashville, TennesseeVanderbilt Medical Center
Feb 23, 2023
Skin Cancer, Non-Melanoma Trial (Surgery with additional moderate hypofractionation RT (15 fractions), Surgery alone, without
Not yet recruiting
- Skin Cancer, Non-Melanoma
- Surgery with additional moderate hypofractionation RT (15 fractions)
- +2 more
- (no location specified)
Mar 20, 2023
Brain Metastases, Radiotherapy Trial in Heidelberg (Preoperative Radiotherapy, Intraoperative Radiation, Postoperative
Not yet recruiting
- Brain Metastases
- Radiotherapy
- Preoperative Radiotherapy
- +2 more
-
Heidelberg, GermanyDepartment of Radiotherapy, University of Heidelberg
May 12, 2023
Breast Cancer, Radiation Dermatitis Trial in Toronto (StrataXRT)
Recruiting
- Breast Cancer
- Radiation Dermatitis
- StrataXRT
-
Toronto, Ontario, CanadaOdette Cancer Centre, Sunnybrook Health Sciences Centre
Oct 25, 2022
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
Cervical Cancer Trial in Prague (No adjuvant therapy, Adjuvant radiotherapy)
Recruiting
- Cervical Cancer
- No adjuvant therapy
- Adjuvant radiotherapy
-
Prague, CzechiaGeneral University Hospital in Prague
Jul 25, 2022
Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) Trial in Baltimore (Chemotherapy with Temodar.,
Terminated
- Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
- Chemotherapy with Temodar.
- Radiation therapy
-
Baltimore, MarylandUmmc Msgcc
Dec 1, 2022
Squamous Cell Carcinoma of the Oropharynx, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Carmel, Indianapolis (44
Recruiting
- Squamous Cell Carcinoma of the Oropharynx
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- 44 doses of radiation
- 54 doses of radiation
-
Carmel, Indiana
- +1 more
Oct 5, 2022
Breast Cancer Trial in New York (Radiation)
Recruiting
- Breast Cancer
- Radiation
-
New York, New York
- +2 more
Jun 29, 2022
Stereotactic Body Radiation Therapy Trial in Beijing (drug adjuvant therapy)
Not yet recruiting
- Stereotactic Body Radiation Therapy
- drug adjuvant therapy
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology Cancer Center, Peking Universit
Jun 6, 2022
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Pancreatic Cancer Trial in Seoul (Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant
Recruiting
- Pancreatic Cancer
- Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant Chemotherapy
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jan 10, 2023
Carcinoma, Squamous Cell of Head and Neck, Oropharynx Squamous Cell Carcinoma Trial in Atlanta, Portland, Pittsburgh (Nivolumab
Active, not recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Oropharynx Squamous Cell Carcinoma
- Nivolumab Injection
- Radiotherapy (RT)
-
Atlanta, Georgia
- +2 more
Mar 24, 2022
Bladder Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer Trial in Atlanta (3D conformal radiation
Terminated
- Bladder Cancer
- +4 more
- 3D conformal radiation therapy
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Feb 14, 2022